Katrine Fabricius

1.3k total citations
39 papers, 1.1k citations indexed

About

Katrine Fabricius is a scholar working on Physiology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Katrine Fabricius has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Pharmacology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Katrine Fabricius's work include Alzheimer's disease research and treatments (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Point processes and geometric inequalities (7 papers). Katrine Fabricius is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Point processes and geometric inequalities (7 papers). Katrine Fabricius collaborates with scholars based in Denmark, Germany and United Kingdom. Katrine Fabricius's co-authors include Bente Pakkenberg, Gitta Wörtwein, Jacob Jelsing, Niels Vrang, Henrik H. Hansen, Pernille Barkholt, Lotte Bjerre Knudsen, Charles Pyke, Anders Fink‐Jensen and Lone Helboe and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Katrine Fabricius

37 papers receiving 1.0k citations

Peers

Katrine Fabricius
J. Brent Kuzmiski Canada
Ágnes Rimanóczy Hungary
Katalin Horváth Hungary
Sheila M. Brooke United States
Peter B. Bongiorno United States
Laura Orío Spain
Marta Valenza Italy
I. Bednar Sweden
Lian Yuan Cao China
Nozdrachev Ad Russia
J. Brent Kuzmiski Canada
Katrine Fabricius
Citations per year, relative to Katrine Fabricius Katrine Fabricius (= 1×) peers J. Brent Kuzmiski

Countries citing papers authored by Katrine Fabricius

Since Specialization
Citations

This map shows the geographic impact of Katrine Fabricius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrine Fabricius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrine Fabricius more than expected).

Fields of papers citing papers by Katrine Fabricius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrine Fabricius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrine Fabricius. The network helps show where Katrine Fabricius may publish in the future.

Co-authorship network of co-authors of Katrine Fabricius

This figure shows the co-authorship network connecting the top 25 collaborators of Katrine Fabricius. A scholar is included among the top collaborators of Katrine Fabricius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrine Fabricius. Katrine Fabricius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaalund, Sanne S., Annette Johansen, Katrine Fabricius, & Bente Pakkenberg. (2020). Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells. Frontiers in Neuroscience. 13. 1398–1398. 10 indexed citations
2.
Holm, Jacob Bak, Albert Pallejá, Pernille Wismann, et al.. (2019). Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice. Scientific Reports. 9(1). 15582–15582. 84 indexed citations
3.
Fabricius, Katrine, Pernille Barkholt, Jacob Jelsing, & Henrik H. Hansen. (2017). Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease. Frontiers in Neuroanatomy. 11. 109–109. 10 indexed citations
4.
Fabricius, Katrine, et al.. (2016). Neocortical Development in Brain of Young Children—A Stereological Study. Cerebral Cortex. 27(12). 5477–5484. 10 indexed citations
5.
Hansen, Henrik H., Katrine Fabricius, Pernille Barkholt, et al.. (2016). Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease. PLoS ONE. 11(7). e0158205–e0158205. 45 indexed citations
6.
Hansen, Henrik H., Katrine Fabricius, Pernille Barkholt, et al.. (2016). Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease. Brain Research. 1646. 354–365. 34 indexed citations
7.
Hansen, Henrik H., Pernille Barkholt, Katrine Fabricius, et al.. (2015). The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy. Brain Research. 1634. 158–170. 77 indexed citations
8.
Dalbøge, Louise S., Philip J. Pedersen, Gitte Hansen, et al.. (2015). A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents. PLoS ONE. 10(8). e0135634–e0135634. 39 indexed citations
9.
Hansen, Henrik H., Katrine Fabricius, Pernille Barkholt, et al.. (2015). The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 46(4). 877–888. 155 indexed citations
10.
Pakkenberg, Bente, et al.. (2014). Stereological estimation of total cell numbers in the human cerebral and cerebellar cortex. Frontiers in Human Neuroscience. 8. 508–508. 41 indexed citations
11.
Fabricius, Katrine, et al.. (2012). Effect of age on neocortical brain cells in 90+ year old human females—a cell counting study. Neurobiology of Aging. 34(1). 91–99. 76 indexed citations
12.
Fabricius, Katrine, Lone Helboe, Anders Fink‐Jensen, et al.. (2010). Increased dopaminergic activity in socially isolated rats: An electrophysiological study. Neuroscience Letters. 482(2). 117–122. 47 indexed citations
13.
Fabricius, Katrine, Lone Helboe, Björn Steiniger‐Brach, Anders Fink‐Jensen, & Bente Pakkenberg. (2010). Stereological brain volume changes in post-weaned socially isolated rats. Brain Research. 1345. 233–239. 28 indexed citations
14.
Fabricius, Katrine, Lone Helboe, Anders Fink‐Jensen, Gitta Wörtwein, & Björn Steiniger‐Brach. (2010). Pharmacological characterization of social isolation-induced hyperactivity. Psychopharmacology. 215(2). 257–266. 33 indexed citations
15.
Fabricius, Katrine, H. Pakkenberg, & Bente Pakkenberg. (2007). No changes in neocortical cell volumes or glial cell numbers in chronic alcoholic subjects compared to control subjects. Alcohol and Alcoholism. 42(5). 400–406. 20 indexed citations
16.
Stark, Amy K., Mette Toft, H. Pakkenberg, et al.. (2007). The effect of age and gender on the volume and size distribution of neocortical neurons. Neuroscience. 150(1). 121–130. 27 indexed citations
17.
Andersen, Birgitte, Katrine Fabricius, H.J.G. Gundersen, Jacob Jelsing, & Amy K. Stark. (2004). No change in neuron numbers in the dentate nucleus of patients with schizophrenia estimated with a new stereological method – the smooth fractionator. Journal of Anatomy. 205(4). 313–321. 16 indexed citations
18.
Müller, Otto, et al.. (1978). [Studies on the diffusion rate of cefamandole in various human tissue (author's transl)].. PubMed. 28(12). 2343–9. 1 indexed citations
19.
Müller, Otto, et al.. (1978). Untersuchungen zur Liquorgängigkeit von Cefamandol. Infection. 6(6). 294–296. 2 indexed citations
20.
Fabricius, Katrine, et al.. (1974). [Determination of cephalothin levels in human tissues].. PubMed. 45(6). 274–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Brent Kuzmiski Breakdown of academic impact, for papers by Ágnes Rimanóczy Breakdown of academic impact, for papers by Katalin Horváth Breakdown of academic impact, for papers by Sheila M. Brooke Breakdown of academic impact, for papers by Peter B. Bongiorno Breakdown of academic impact, for papers by Laura Orío Breakdown of academic impact, for papers by Marta Valenza Breakdown of academic impact, for papers by I. Bednar Breakdown of academic impact, for papers by Lian Yuan Cao Breakdown of academic impact, for papers by Nozdrachev Ad
Rankless by CCL
2026